(Q40286302)

19 September 2017

title

Sindbis virus replicon particles encoding calreticulin linked to a tumor antigen generate long-term tumor-specific immunity (English)

1 reference

19 September 2017

0 references

2

1 reference

19 September 2017

Cheng WF

1

1 reference

19 September 2017

Su YN

3

1 reference

19 September 2017

Chai CY

4

1 reference

19 September 2017

Chang MC

5

1 reference

19 September 2017

Polo JM

6

1 reference

19 September 2017

Hung CF

7

1 reference

19 September 2017

Wu TC

8

1 reference

19 September 2017

Hsieh CY

9

1 reference

19 September 2017

Chen CA

10

1 reference

19 September 2017

publication date

28 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

13

1 reference

19 September 2017

issue

9

1 reference

19 September 2017

page(s)

873-885

1 reference

Calreticulin: not just another calcium-binding protein

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

TAP-translocated peptides specifically bind proteins in the endoplasmic reticulum, including gp96, protein disulfide isomerase and calreticulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Sindbis virus: an efficient, broad host range vector for gene expression in animal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Alphavirus vectors for gene expression and vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Alphavirus-based expression vectors: strategies and applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Cancer therapy using a self-replicating RNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Alphavirus replicon particles containing the gene for HER2/neu inhibit breast cancer growth and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Infection of human dendritic cells by a sindbis virus replicon vector is determined by a single amino acid substitution in the E2 glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Cancer immunotherapy using Sindbis virus replicon particles encoding a VP22-antigen fusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Heat shock proteins transfer peptides during antigen processing and CTL priming

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Monoclonal antibodies directed to the erbB-2 receptor inhibit in vivo tumour cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700956

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700956

1 reference

Dimensions Publication ID

19 September 2017

1030019511

0 references

1 reference